作者:
Julija,Hmeljak [1]
;
Francisco,Sanchez-Vega [2]
;
Katherine A,Hoadley [3]
;
Juliann,Shih [4]
;
Chip,Stewart [3]
;
David,Heiman [3]
;
Patrick,Tarpey [5]
;
Ludmila,Danilova [6]
;
Esther,Drill [7]
;
Ewan A,Gibb [8]
;
Reanne,Bowlby [9]
;
Rupa,Kanchi [10]
;
Hatice U,Osmanbeyoglu [11]
;
Yoshitaka,Sekido [12]
;
Jumpei,Takeshita [13]
;
Yulia,Newton [14]
;
Kiley,Graim [14]
;
Manaswi,Gupta [4]
;
Carl M,Gay [15]
;
Lixia,Diao [10]
;
David L,Gibbs [16]
;
Vesteinn,Thorsson [16]
;
Lisa,Iype [16]
;
Havish,Kantheti [17]
;
David T,Severson [18]
;
Gloria,Ravegnini [19]
;
Patrice,Desmeules [20]
;
Achim A,Jungbluth [21]
;
William D,Travis [21]
;
Sanja,Dacic [22]
;
Lucian R,Chirieac [23]
;
Françoise,Galateau-Sallé [24]
;
Junya,Fujimoto [25]
;
Aliya N,Husain [26]
;
Henrique C,Silveira [27]
;
Valerie W,Rusch [28]
;
Robert C,Rintoul [29]
;
Harvey,Pass [30]
;
Hedy,Kindler [31]
;
Marjorie G,Zauderer [32]
;
David J,Kwiatkowski [33]
;
Raphael,Bueno [18]
;
Anne S,Tsao [15]
;
Jenette,Creaney [34]
;
Tara,Lichtenberg [35]
;
Kristen,Leraas [35]
;
Jay,Bowen [35]
;
TCGA Research Network [36]
;
Ina,Felau [36]
;
Jean Claude,Zenklusen [10]
;
Rehan,Akbani [4]
;
Andrew D,Cherniack [18]
;
Lauren A,Byers [4]
;
Michael S,Noble [22]
;
Jonathan A,Fletcher [9]
;
A Gordon,Robertson [7]
;
Ronglai,Shen [13]
;
Hiroyuki,Aburatani [34]
;
Bruce W,Robinson [5]
;
Peter,Campbell [37]
;
Marc,Ladanyi
作者单位:
Department of Pathology and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
[1]
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
[2]
Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
[3]
The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
[4]
Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.
[5]
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.
[6]
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
[7]
GenomeDx Biosciences, Vancouver, British Columbia, Canada.
[8]
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
[9]
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[10]
Computational Systems Biology, Memorial Sloan Kettering Cancer Center, New York, New York.
[11]
Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
[12]
Genome Science Division, The University of Tokyo, Tokyo, Japan.
[13]
Department of Biomolecular Engineering and Center for Biomolecular Science and Engineering, University of California, Santa Cruz, Santa Cruz, California.
[14]
Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[15]
Institute for Systems Biology, Seattle, Washington.
[16]
The University of Texas at Dallas, Richardson, Texas.
[17]
Division of Thoracic Surgery, The Lung Center and International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts.
[18]
Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
[19]
Department of Pathology, Quebec Heart and Lung Institute, Quebec, Canada.
[20]
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
[21]
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
[22]
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
[23]
MESOPATH. Cancer Center Leon Berard, Lyon, France.
[24]
Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[25]
Department of Pathology, University of Chicago, Chicago, Illinois.
[26]
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil.
[27]
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
[28]
Department of Oncology, University of Cambridge, Cambridge, UK.
[29]
Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, New York.
[30]
Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois.
[31]
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
[32]
Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
[33]
School of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia.
[34]
The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
[35]
National Cancer Institute, Bethesda, Maryland.
[36]
Department of Pathology and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. ladanyim@mskcc.org.
[37]
主题词
老年人(Aged);女(雌)性(Female);组蛋白赖氨酸N-甲基转移酶(Histone-Lysine N-Methyltransferase);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);肺肿瘤(Lung Neoplasms);男(雄)性(Male);间皮瘤(Mesothelioma);中年人(Middle Aged);突变(Mutation);胸膜肿瘤(Pleural Neoplasms);预后(Prognosis);蛋白甲基转移酶类(Protein Methyltransferases);肿瘤抑制蛋白质类(Tumor Suppressor Proteins);泛素硫酯酶(Ubiquitin Thiolesterase)
DOI
10.1158/2159-8290.CD-18-0804
PMID
30322867
发布时间
2022-04-05
- 浏览12

Cancer discovery
Cancer discovery
1548-1565页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文